Switch theme
Sign up to access all valuation multiples
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
2014
4.5K+
LTM Revenue $2.3B
LTM EBITDA $157M
$1.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Evolent Health has a last 12-month revenue (LTM) of $2.3B and a last 12-month EBITDA of $157M.
In the most recent fiscal year, Evolent Health achieved revenue of $2.6B and an EBITDA of $80.1M.
Evolent Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Evolent Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3B | XXX | $2.6B | XXX | XXX | XXX |
| Gross Profit | $386M | XXX | $367M | XXX | XXX | XXX |
| Gross Margin | 16% | XXX | 14% | XXX | XXX | XXX |
| EBITDA | $157M | XXX | $80.1M | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 3% | XXX | XXX | XXX |
| EBIT | $64.4M | XXX | -$14.1M | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | -1% | XXX | XXX | XXX |
| Net Profit | $39.5M | XXX | -$61.6M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | -2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $558M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Evolent Health's stock price is $7.
Evolent Health has current market cap of $875M, and EV of $1.5B.
See Evolent Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.5B | $875M | XXX | XXX | XXX | XXX | $0.39 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Evolent Health has market cap of $875M and EV of $1.5B.
Evolent Health's trades at 0.6x EV/Revenue multiple, and 18.7x EV/EBITDA.
Equity research analysts estimate Evolent Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Evolent Health has a P/E ratio of 22.2x.
See valuation multiples for Evolent Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $875M | XXX | $875M | XXX | XXX | XXX |
| EV (current) | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | 9.6x | XXX | 18.7x | XXX | XXX | XXX |
| EV/EBIT | 23.3x | XXX | -106.5x | XXX | XXX | XXX |
| EV/Gross Profit | 3.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 22.2x | XXX | -14.2x | XXX | XXX | XXX |
| EV/FCF | 254.8x | XXX | -244.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEvolent Health's last 12 month revenue growth is -7%
Evolent Health's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.1M for the same period.
Evolent Health's rule of 40 is -8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Evolent Health's rule of X is -10% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Evolent Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -7% | XXX | -3% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -8% | XXX | -4% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -10% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Star Health Insurance | XXX | XXX | XXX | XXX | XXX | XXX |
| Hapvida | XXX | XXX | XXX | XXX | XXX | XXX |
| Qualicorp | XXX | XXX | XXX | XXX | XXX | XXX |
| Accolade | XXX | XXX | XXX | XXX | XXX | XXX |
| AIX Inc. | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Evolent Health acquired XXX companies to date.
Last acquisition by Evolent Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Evolent Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Evolent Health founded? | Evolent Health was founded in 2014. |
| Where is Evolent Health headquartered? | Evolent Health is headquartered in United States of America. |
| How many employees does Evolent Health have? | As of today, Evolent Health has 4.5K+ employees. |
| Who is the CEO of Evolent Health? | Evolent Health's CEO is Mr. Seth Blackley. |
| Is Evolent Health publicy listed? | Yes, Evolent Health is a public company listed on NYS. |
| What is the stock symbol of Evolent Health? | Evolent Health trades under EVH ticker. |
| When did Evolent Health go public? | Evolent Health went public in 2015. |
| Who are competitors of Evolent Health? | Similar companies to Evolent Health include e.g. Star Health Insurance, Hapvida, Qualicorp, Accolade. |
| What is the current market cap of Evolent Health? | Evolent Health's current market cap is $875M |
| What is the current revenue of Evolent Health? | Evolent Health's last 12 months revenue is $2.3B. |
| What is the current revenue growth of Evolent Health? | Evolent Health revenue growth (NTM/LTM) is -7%. |
| What is the current EV/Revenue multiple of Evolent Health? | Current revenue multiple of Evolent Health is 0.6x. |
| Is Evolent Health profitable? | Yes, Evolent Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Evolent Health? | Evolent Health's last 12 months EBITDA is $157M. |
| What is Evolent Health's EBITDA margin? | Evolent Health's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Evolent Health? | Current EBITDA multiple of Evolent Health is 9.6x. |
| What is the current FCF of Evolent Health? | Evolent Health's last 12 months FCF is $5.9M. |
| What is Evolent Health's FCF margin? | Evolent Health's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Evolent Health? | Current FCF multiple of Evolent Health is 254.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
